Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(50%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
1
17%
Ph phase_3
1
17%
Ph phase_2
3
50%

Phase Distribution

0

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(2)
Other(1)

Detailed Status

Recruiting3
Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (60.0%)
Phase 31 (20.0%)
N/A1 (20.0%)

Trials by Status

completed233%
recruiting350%
unknown117%

Recent Activity

3 active trials
Showing 5 of 6
completedphase_2

Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy

NCT02203695
recruitingnot_applicable

Improving Therapeutic Ratio With Hypo Fractionated Stereotactic Radiotherapy for Brain Metastases

NCT05346367
recruitingphase_2

Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer

NCT06305832
recruitingphase_2

Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer

NCT05753566
unknownphase_3

Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy

NCT05111197
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT02203695Phase 2

Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy

Completed
NCT05346367Not Applicable

Improving Therapeutic Ratio With Hypo Fractionated Stereotactic Radiotherapy for Brain Metastases

Recruiting
NCT06305832Phase 2

Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer

Recruiting
NCT05753566Phase 2

Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer

Recruiting
NCT05111197Phase 3

Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy

Unknown
NCT02814201

Study of Motor Slowing in Parkinson's Disease by a Computerized Mental Chronometry Paradigm

Completed

All 6 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
6